Meningioma 1 gene is differentially expressed in CD34 positive cells from bone marrow of patients with myelodysplastic syndromes with the highest expression in refractory anemia with excess of blasts and secondary acute myeloid leukemia

Thomas Schroeder Department for Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, GermanyCorrespondence[email protected]

Akos Czibere Department for Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany

Fabian Zohren Department for Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany

Manuel Aivado Department for Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany

Norbert Gattermann Department for Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany

Ulrich Germing Department for Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany

Rainer Haas Department for Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany

show all

Meningioma 1 gene is differentially expressed in CD34 positive cells from bone marrow of patients with myelodysplastic syndromes with the highest expression in refractory anemia with excess of blasts and secondary acute myeloid leukemia

Information for

Open access

Opportunities

Help and information

Meningioma 1 gene is differentially expressed in CD34 positive cells from bone marrow of patients with myelodysplastic syndromes with the highest expression in refractory anemia with excess of blasts and secondary acute myeloid leukemia

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature